Orthokeratology and 0.01% Atropine Sequential Treatment for Myopia Control

NCT06667037 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

194

Enrollment

OTHER

Sponsor class

Conditions

Myopia

Interventions

DEVICE: Ortho-k lenses
DRUG: 0.01% Atropine

Sponsor

Zhongshan Ophthalmic Center, Sun Yat-sen University

Collaborators

[object Object]
[object Object]
[object Object]